U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003.

  • By agreement with the publisher, this book is accessible by the search feature, but cannot be browsed.
Cover of Holland-Frei Cancer Medicine

Holland-Frei Cancer Medicine. 6th edition.

Show details

References

, MD, , MD, , MD, and , MD.

1.
Long ER. A history of pathology. Baltimore, MD: Williams & Wilkins; 1928.
2.
Czerny V . Neue Operationen. Vorlaufige Mittheilung Zentralb Cir. 1877;4:433–4.
3.
Torek F . The first successful case of resection of the thoracic portion of the esophagus for carcinoma. Surg Gynecol Obstet. 1913;16:614–7.
4.
Dolan K , Sutton R , Walker SJ . et al. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer. 1999;80:834–42. [PMC free article: PMC2362302] [PubMed: 10360663]
5.
Siewert JR . Adenocarcinoma of the esophagogastric junction: classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82.
6.
Caldwell CB , Bains MS , Burt M . Unusual malignant neoplasms of the esophagus. J Thorac Cardiovasc Surg. 1991;101:100–7. [PubMed: 1702494]
7.
Lieberman MD , Franceschi D , Marsan B . et al. Esophageal carcinoma. The unusual variants. J Thorac Cardiovasc Surg. 1994;108:1138–46. [PubMed: 7983884]
8.
Craddock VM . Aetiology of oesophageal cancer: some operative factors. Eur J Cancer Prevent. 1992;1:89–103. [PubMed: 1463984]
9.
Kinjo Y , Cui Y , Akiba S . et al. Mortality risks of oesophageal cancer associated with hot tea, alcohol, tobacco, and diet in Japan. J Epidemiol. 1998;8:235–43. [PubMed: 9816815]
10.
Heimburger DC . Localized deficiencies of folic acid in aerodigestive tissues. Ann NY Acad Sci. 1992;669:87–95. [PubMed: 1444061]
11.
Ghadirian P , Vobecky J , Vobecky JS . Factors associated with cancer of the oesophagus: an overview. Cancer Detect Prevent. 1988;11:225–34. [PubMed: 3292043]
12.
Jaskiewicz K , Marasas FO , Rossouw JE . et al. Selenium and other mineral elements in populations at risk for esophageal cancer. Cancer. 1988;62:2635–9. [PubMed: 3191467]
13.
Kjaerheim K , Gaard M , Andersen A . The role of alcohol, tobacco, and dietary factors in upper aerodigestive tract cancers: a prospective study of 10,900 Norwegian men. Cancer Causes Controls. 1998;9:99–108. [PubMed: 9486469]
14.
Yu MC , Garabrant DH , Peters JM . et al. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res. 1988;48:3843–8. [PubMed: 3378219]
15.
Castellsague X , Munoz N , De Stefani E . et al. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer. 1999;82:657–64. [PubMed: 10417762]
16.
Lagergren J , Bergstrom R , Lindgren A . et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31. [PubMed: 10080844]
17.
O'Connor JB , Falk GW , Richter JE . The incidence of adenocarcinoma and dysplasia in Barrett's esophagus. Am J Gastroenterol. 1999;94:2037–42. [PubMed: 10445525]
18.
Sammon AM , Alderson D . Diet, reflux, and the development of squamous cell carcinoma of the oesophagus in Africa. Br J Surg. 1998;85:891–6. [PubMed: 9692558]
19.
Meijssen MAC , Tilanus HW , van Blankenstein M . et al. Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients. Gut. 1992;33:155–8. [PMC free article: PMC1373921] [PubMed: 1541408]
20.
Sandler RS , Nyren O , Ekborn A . et al. The risk of esophageal cancer in patients with achalasia. JAMA. 1995;274:1359–62. [PubMed: 7563560]
21.
Streitz JM Jr, Ellis FH Jr, Gibb SP . et al. Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients. Ann Thorac Surg. 1995;59:1604–9. [PubMed: 7771859]
22.
Yang PC , Davis S . Incidence of cancer of the esophagus in the U.S. by histologic type. Cancer. 1988;61:612–7. [PubMed: 3338027]
23.
Maillefer RH , Greydanus MP . To B or not to B: is tylosis B truly benign? Am J Gastroenterol. 1999;94:829–34. [PubMed: 10086674]
24.
Montesano R , Hollstein M , Hainaut P . Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer. 1996;69:225–35. [PubMed: 8682592]
25.
Sur M , Cooper K . The role of the human papilloma virus in esophageal cancer. Pathology. 1998;30:348–54. [PubMed: 9839308]
26.
Bjorge T , Hakulinen T , Engeland A . et al. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res. 1997;57:3989–92. [PubMed: 9307283]
27.
Lagergren J , Wang Z , Bergstrom R . et al. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst. 1999;91:156–62. [PubMed: 9923857]
28.
Dawsey SM , Shen Q , Nieberg RK . et al. Studies of esophageal balloon cytology in Linxian, China. Cancer Epidermiol Biomarkers Prev. 1997;6:121–30. [PubMed: 9037563]
29.
Yang CS . Research on esophageal cancer in China: a review. J Thorac Cardiovasc Surg. 1980;40:2633–44. [PubMed: 6992989]
30.
Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1973-1999, Bethesda, MD: National Cancer Institute; 2002.
31.
Jemal A , Murray T , Samuels A . et al. Cancer statistics, 2003. CA cancer J Clin. 2003;53:5–26. [PubMed: 12568441]
32.
Pera M , Cameron AJ , Trastek VF . et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510–3. [PubMed: 8425693]
33.
Maram ES , Kurland LT , Ludwig J . et al. Esophageal carcinoma in Olmsted County, Minnesota, 1935-1971. Mayo Clin Proc. 1977;52:24–7. [PubMed: 609282]
34.
Hesketh PJ , Clapp RW , Doos WG . et al. The increasing frequency of adenocarcinoma of the esophagus. Cancer. 1989;64:526–30. [PubMed: 2736498]
35.
Powell J , McConkey CC . Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer. 1990;62:440–3. [PMC free article: PMC1971432] [PubMed: 2206952]
36.
Levi F , LaVecchia C . Adenocarcinoma of the esophagus in Switzerland. JAMA. 1991;265:2960. [PubMed: 2033763]
37.
Bytzer P , Christensen PB , Damkier P . et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol. 1999;94:86–91. [PubMed: 9934736]
38.
Swisher SG , Hunt KK , Holmes EC . et al. Changes in the surgical management of esophageal cancer from 1970-1993. Am J Surg. 1995;169:609–14. [PubMed: 7771626]
39.
Swisher SG , Holmes EC , Hunt KK . et al. The role of neoadjuvant therapy in surgical resection of esophageal cancer. Arch Surg. 1996;131:819–25. [PubMed: 8712904]
40.
Roth JA , Pass HI , Flanagan MM . et al. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg. 1988;96:242–8. [PubMed: 2456424]
41.
Cusso X , Mones-Xiol J , Vilardell F . Endoscopic cytology of cancer of the esophagus and cardia: a long-term evaluation. Gastrointest Endosc. 1989;35:321–3. [PubMed: 2767385]
42.
Ritchie AJ , McGuigan J , McManus K . et al. Diagnostic rigid and flexible oesophagoscopy in carcinoma of the oesophagus: a comparison. Thorax. 1993;48:115–8. [PMC free article: PMC464284] [PubMed: 8493622]
43.
Law SYK , Fok M , Wong J . Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg. 1994;18:339–46. [PubMed: 8091773]
44.
Swisher SG , DeFord L , Merriman KW . et al. Effect of operative volume on morbidity, mortality and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000;119:1126–34. [PubMed: 10838528]
45.
Tio TL , Coene PPLO , Luiken GJHM . et al. Endosonography in the clinical staging of esophageal carcinoma [abstract] Gastrointest Endosc. 1990;36:S2–S10. [PubMed: 2184081]
46.
Beseth BD , Bedrod R , Isacoff WH . et al. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg. 2002;66:827–31. [PubMed: 10993609]
47.
Romagnuolo J , Scott J , Hawes RH . et al. Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc. 2002;55:648–54. [PubMed: 11979245]
48.
Peters JH , Hoeft SF , Heimbucher J . et al. Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. Arch Surg. 1994;129:534–9. [PubMed: 7514396]
49.
Rice TW , Boyce GA , Sivak MV . Esophageal ultrasound and the preoperative staging of carcinoma of the esophagus. J Thorac Cardiovasc Surg. 1991;101:536–44. [PubMed: 1999948]
50.
Parmar KS , Zwishcenberger JB , Reevers AL . et al. Clinical impact of endoscopic ultrasound-guided fine needed aspiration of celiac axis lymph nodes (M1a disease) in esophageal cancer. Ann Thorac Surg. 2002;73:916–21. [PubMed: 11899201]
51.
Thompson WM , Halvorsen RA , Foster WL Jr. et al. Computed tomography for staging esophageal and gastroesophageal cancer: reevaluation. AJR Am J Roentgenol. 1983;141:951–8. [PubMed: 6605068]
52.
Lehr L , Rupp N , Siewert JR . Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging. Surgery. 1988;103:344–50. [PubMed: 3344487]
53.
Yasui A , Nimura Y , Hayakawa N . MRI and CT of intrathoracic esophageal carcinoma: radiological, surgical and histopathological correlation. Dis Esoph. 1990;3:13–20.
54.
Schroder W , Baldus SE , Monig SP . et al. Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis. World J Surg. 2002;26:584–7. [PubMed: 12098049]
55.
Greenberg J , Durkin M , Van Drunen M . et al. Computed tomography or endoscopic ultrasonography in preoperative staging of gastric and esophageal tumors. Surgery. 1994;116:696–702. [PubMed: 7940168]
56.
Quint LE , Glazer GM , Orringer MB . Esophageal imaging by MR and CT: study of normal anatomy and neoplasms. Radiology. 1985;156:727–31. [PubMed: 4023234]
57.
Krasna MJ , Reed CE , Jaklitsch MT . et al. Thoracoscopic staging of esophageal cancer: a prospective, multiinstitutional trial. Ann Thorac Surg. 1995;60:1337–40. [PubMed: 8526623]
58.
Watt I , Stewart I , Anderson D . et al. Laparoscopy, ultrasound and computed tomography in cancer of the oesophagus and gastric cardia: a prospective comparison for detecting intra-abdominal metastases. Br J Surg. 1989;76:1036–9. [PubMed: 2532050]
59.
Block MI , Patterson GA , Sundaresan RS . et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg. 1997;64:770–7. [PubMed: 9307472]
60.
Riedel M , Hauck RW , Stein HJ . et al. Preoperative bronchoscopic assessment of airway invasion by esophageal cancer. Chest. 1998;113:687–95. [PubMed: 9515844]
61.
Flamen P , Lerut A , Van Cutsem E . et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202–10. [PubMed: 10986052]
62.
Brucher BLDM , Weber W , Bauer M . et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg. 2001;233:300–9. [PMC free article: PMC1421244] [PubMed: 11224616]
63.
Flamen P , Lerut A , Van Cutsem E . et al. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg. 2000;120:1085–92. [PubMed: 11088030]
64.
Inculet R , Keller SM , Dwyer A . et al. Evaluation of noninvasive tests for the preoperative staging of carcinoma of the esophagus: a prospective study. Ann Thorac Surg. 1985;40:561–5. [PubMed: 4074004]
65.
Tachimori Y , Kato H , Watanabe H . et al. Neck ultrasonography for thoracic esophageal carcinoma. Ann Thorac Surg. 1994;57:1180–3. [PubMed: 8179382]
66.
Natsugoe S , Yoshinaka H , Shimada M . et al. Assessment of cervical lymph node metastasis in esophageal carcinoma using ultrasonography. Ann Surg. 1999;229:62–6. [PMC free article: PMC1191609] [PubMed: 9923801]
67.
van Overhagen H , Lameris JS , Zonderland HM . et al. Ultrasound and ultrasound-guided fine needle aspiration biopsy of supraclavicular lymph nodes in patients with esophageal carcinoma. Cancer. 1991;67:585–7. [PubMed: 1985752]
68.
Krasna MJ , Flowers JL , Attar S . et al. Combined thoracoscopic/laparoscopic staging of esophageal cancer. J Thorac Cardiovasc Surg. 1996;111:800–7. [PubMed: 8614140]
69.
Stein HJ , Kraemer SJM , Feussner H . et al. Clinical value of diagnostic laparoscopy with laparoscopic ultrasound in patients with cancer of the esophagus and cardia. J Gastrointest Surg. 1997;1:167–73. [PubMed: 9834344]
70.
Mufti SI , Zirvi KA , Garewal HS . Precancerous lesions and biologic markers in esophageal cancer. Cancer Detect Prev. 1991;15:291–301. [PubMed: 1794136]
71.
Shimada Y , Imamura M , Shibagaki I . et al. Genetic alterations in patients with esophageal cancer with short-and long-term survival rates after curative esophagectomy. Ann Surg. 1997;226:162–8. [PMC free article: PMC1190950] [PubMed: 9296509]
72.
Wang L-S , Chow K-H , Chi K-H . et al. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol. 1999;94:1933–40. [PubMed: 10406262]
73.
American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 1997. p. 65–9.
74.
Korst RJ , Rusch VW , Venkatraman E . et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg. 1998;115:660–70. [PubMed: 9535455]
75.
Baba M , Aikou T , Yoshinaka H . et al. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg. 1994;219:310–6. [PMC free article: PMC1243140] [PubMed: 8147613]
76.
Holscher AH , Bollschweiler E , Bumm R . et al. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery. 1995;118:845–55. [PubMed: 7482272]
77.
Nishimaki T , Suzuki T , Suzuki S . et al. Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg. 1998;186:306–12. [PubMed: 9510261]
78.
Nigro JJ , DeMeester SR , Hagen JA . et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg. 1999;117:960–8. [PubMed: 10220691]
79.
Tabira Y , Okuma T , Kondo K . et al. Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus. J Thorac Cardiovasc Surg. 1999;117:239–45. [PubMed: 9918963]
80.
Japanese Committee for Registration of Esophageal Carcinoma. A proposal for a new TNM classification of esophageal carcinoma. Jpn J Clin Oncol. 1985;14:625–36. [PubMed: 4094095]
81.
Hofstetter W , Swisher SG , Correa AM . et al. Treatment outcomes of resected esophageal cancer. Ann Surg. 2002;236:376–85. [PMC free article: PMC1422591] [PubMed: 12192324]
82.
Mizobuchi S , Kato H , Tachimori Y . et al. Multiple primary carcinoma of the oesophagus. Surg Oncol. 1993;2:249–253. [PubMed: 8252216]
83.
Pesko P , Rakic S , Milicevic M . et al. Prevalence and clinicopathologic features of multiple squamous cell carcinoma of the esophagus. Cancer. 1994;73:2687–90. [PubMed: 8194006]
84.
Jacobi CA , Zieren HU , Muller JM . et al. Surgical therapy of esophageal carcinoma: the influence of surgical approach and esophageal resection on cardiopulmonary function. Eur J Cardio-Thorac Surg. 1997;11:32–7. [PubMed: 9030787]
85.
Moon MR , Schulte WJ , Haasler GB . et al. Transhiatal and transthoracic esophagectomy for adenocarcinoma of the esophagus. Arch Surg. 1992;127:951–5. [PubMed: 1642537]
86.
Pac M , Basoglu A , Kocak H . et al. Transhiatal versus transthoracic esophagectomy for esophageal cancer. J Thorac Cardiovasc Surg. 1993;106:205–9. [PubMed: 8341062]
87.
Tilanus HW , Hop WCJ , Langenhorst BLAM . et al. Esophagectomy with or without thoracotomy. J Thorac Cardiovasc Surg. 1993;105:898–903. [PubMed: 8487568]
88.
Putnam JB Jr, Suell DM , McMurtry MJ . et al. Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg. 1994;57:319–25. [PubMed: 8311591]
89.
Gluch L , Smith RC , Bambach CP . et al. Comparison of outcomes following transhiatal or Ivor Lewis esophagectomy for esophageal carcinoma. World J Surg. 1999;23:271–6. [PubMed: 9933699]
90.
Rindani R , Martin CJ , Cox MR . Transhiatal versus Ivor Lewis oesophagectomy: is there a difference? Aust NZ J Surg. 1999;69:187–94. [PubMed: 10075357]
91.
McAnena OJ , Rogers J , Williams NS . Right thoracoscopically assisted oesophagectomy for cancer. Br J Surg. 1994;81:236–8. [PubMed: 8156345]
92.
Liu H-P , Chang C-H , Lin PJ . et al. Video-assisted endoscopic esophagectomy with stapled intrathoracic esophagogastric anastomosis. World J Surg. 1995;19:745–7. [PubMed: 7571674]
93.
Akaishi T , Kaneda I , Higuchi N . et al. Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy. J Thorac Cardiovasc Surg. 1996;112:1533–40. [PubMed: 8975845]
94.
Dexter SPL , Martin IG , McMahon MJ . Radical thoracoscopic esophagectomy for cancer. Surg Endosc. 1996;10:147–51. [PubMed: 8932617]
95.
Roberston GS , Lloyd DM , Wicks AC . et al. No obvious advantages for thoracoscopic two-stage oesophagectomy. Br J Surg. 1996;83:675–8. [PubMed: 8689217]
96.
Law S , Fok M , Chu KM . et al. Thoracoscopic esophagectomy for esophageal cancer. Surgery. 1997;122:8–14. [PubMed: 9225908]
97.
Peracchia A , Rosati R , Funagalli U . et al. Thoracoscopic dissection of the esophagus for cancer. Int J Surg. 1997;82:1–4. [PubMed: 9189787]
98.
Kawahara K , Maikawa T , Okabayashi K . et al. Video-assisted thoracoscopic esophagectomy for esophageal cancer. Surg Endosc. 1999;13:218–23. [PubMed: 10064749]
99.
Skinner DB , Little AG , Ferguson MK . et al. Selection of operation for esophageal cancer based on staging. Ann Surg. 1986;204:391–401. [PMC free article: PMC1251306] [PubMed: 2429625]
100.
Siewert JR , Roder JD . Lymphadenectomy in esophageal cancer surgery. Dis Esoph. 1992;5:91–7.
101.
Orringer MB , Marshall B , Sterling MC . Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg. 1993;105:265–77. [PubMed: 8429654]
102.
Hagen JA , Peters JH , DeMeester TR . Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg. 1993;106:850–9. [PubMed: 8231207]
103.
Altorki N , Girardi L , Skinner DB . Esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997;114:948–56. [PubMed: 9434690]
104.
Ide H, Hanyu F, Murata Y, et al. Extended dissection for thoracic esophageal cancer based on preoperative staging. In: Ferguson M, Little AG, Skinner DB, editors. Diseases of the esophagus. Vol I. Malignant diseases. Mount Kisco, NY: Futura; 1990. p. 177–86.
105.
Akiyama H , Tsurumaru M , Udagawa H . et al. Systematic lymph node dissection for esophageal cancer-effective or not? Dis Esoph. 1994;7:2–13.
106.
Altorki NK , Skinner DB . Occult cervical nodal metastases in esophageal cancer: preliminary results of three-field lymphadenectomy. J Thorac Cardiovasc Surg. 1997;113:540–4. [PubMed: 9081100]
107.
van de Ven C , De Leyn P , Coosemans W . et al. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and gastro-esophageal junction. Eur J Cardio-Thorac Surg. 1999;15:769–73. [PubMed: 10431857]
108.
Nishihira T , Mori S , Hirayama K . Extensive lymph node dissection for thoracic esophageal carcinoma. Dis Esoph. 1992;5:79–89.
109.
Peracchia A , Ruol A , Bardini R . et al. Lymph node dissection for cancer of the thoracic esophagus: how extended should it be? Dis Esoph. 1992;5:69–78.
110.
Fujita H , Kakegawa T , Yamana H . et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg. 1995;222:654–62. [PMC free article: PMC1234993] [PubMed: 7487213]
111.
Akiyama H , Tsurumaru M , Udagawa H . et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–73. [PMC free article: PMC1234394] [PubMed: 8092902]
112.
Lerut T , Coosemans W , De Leyn P . et al. Reflections on three field lymphadenectomy in carcinoma of the esophagus and esophagogastric junction. Hepato-Gastroenterol. 1999;46:717–25. [PubMed: 10370600]
113.
Schlag PM . Chirirgische Arbeitsgemeinschaft fuer Onkologie der Deutschen Gesellschaft fuer Chirurgie Study Group. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg. 1992;127:1446–50. [PubMed: 1365692]
114.
Walsh TN , Noonan N , Hollywood D . et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–7. [PubMed: 8672151]
115.
Bosset J-F , Gignoux M , Triboulet J-P . et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med. 1997;337:161–7. [PubMed: 9219702]
116.
Law S , Fok M , Chow S . et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg. 1997;114:210–7. [PubMed: 9270638]
117.
Kelsen DP , Ginsberg R , Pajak TF . et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979–84. [PubMed: 9869669]
118.
Chakkaphak S , Krishnasamy S , Walker SJ . et al. Treatment of carcinoma of the proximal esophagus. Surg Gynecol Obstet. 1989;168:307–10. [PubMed: 2928905]
119.
Mansour KA , Picone AL , Coleman JJ III. Surgery for high cervical esophageal carcinoma: experience with 11 patients. Ann Thorac Surg. 1990;49:597–602. [PubMed: 2322055]
120.
Kelley DJ , Wolf R , Shaha AR . et al. Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg. 1995;170:427–31. [PubMed: 7485725]
121.
Marmuse J-P , Koka VN , Guedon C . et al. Surgical treatment of carcinoma of the proximal esophagus. Am J Surg. 1995;169:386–90. [PubMed: 7535016]
122.
Ribet M , Debrueres B , Lecomte-Houcke M . Resection for advanced cancer of the thoracic esophagus: cervical or thoracic anastomosis? J Thorac Cardiovasc Surg. 1992;103:784–9. [PubMed: 1548922]
123.
Gawad KA , Hosch SB , Bumann D . et al. How important is the route of reconstruction after esophagectomy: a prospective randomized study. Am J Gastroenterol. 1999;94:1490–6. [PubMed: 10364012]
124.
Minsky BD , Pajak TF , Ginsberg RJ . et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167–74. [PubMed: 11870157]
125.
Schuchmann G , Heydorn W , Hall R . et al. The treatment of esophageal carcinoma. A retrospective review. J Thorac Cardiovasc Surg. 1980;79:67–73. [PubMed: 6153115]
126.
Newaishy G , Read G , Duncan W . et al. Results of radical radiation therapy of squamous cell carcinoma of the oesophagus. Clin Radiol. 1982;33:347–52. [PubMed: 7075142]
127.
Yin W , Zhang L , Miao Y . et al. The results of high-energy electron therapy in carcinoma of the oesophagus compared with telecobalt. Clin Radiol. 1983;34:113–6. [PubMed: 6401610]
128.
Morita K , Takagi I , Watanabe M . et al. Relationship between radiologic features of esophageal cancer and local control by radiation therapy. Cancer. 1985;55:2668–76. [PubMed: 3995477]
129.
Mendenhall WM , Parsons JT , Cassisi NJ . et al. Carcinoma of the cervical esophagus treated with radiation therapy. Laryngoscope. 1988;98:769–71. [PubMed: 3386384]
130.
Araujo CMM , Souhami L , Gil RA . et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer. 1991;67:2258–61. [PubMed: 1707338]
131.
Smith TJ , Ryan LM , Douglass HO Jr. et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42:269–76. [PubMed: 9788404]
132.
Sykes AJ , Burt PA , Slevin NJ . et al. Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiother Oncol. 1998;48:1–21. [PubMed: 9756167]
133.
Cooper JS , Guo MD , Herskovic A . et al. Chemoradiotherapy of locally advanced esophageal cancer. JAMA. 1999;281:1623–7. [PubMed: 10235156]
134.
Roussel A , Bleiberg H , Dalesio O . et al. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial. Int J Radiat Oncol Biol Phys. 1989;16:67–72. [PubMed: 2463980]
135.
Hatlevoll R , Hagen S , Hansen HS . et al. Bleomycin/cisplatin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. Radiother Oncol. 1992;24:114–6. [PubMed: 1379740]
136.
Slabber CF , Nel JS , Schoeman L . et al. A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol. 1998;21:462–5. [PubMed: 9781600]
137.
Badwe RA , Sharma V , Bhansali MS . et al. The quality of swallowing for patients with operable esophageal carcinoma: a randomized trial comparing surgery with radiotherapy. Cancer. 1999;85:763–8. [PubMed: 10091752]
138.
Launois B , Delarue D , Campion JP . Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet. 1981;153:690–2. [PubMed: 6794167]
139.
Gignoux M , Roussel A , Paillot B . et al. The value of preoperative radiotherapy in esophageal cancer: results of a study by the EORTC. Recent Rep Cancer Res. 1988;110:1–13. [PubMed: 3043582]
140.
Wang M , Gu XZ , Yin WB . et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys. 1989;16:325–7. [PubMed: 2646253]
141.
Arnott SJ , Duncan W , Kerr GR . et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol. 1992;24:108–13. [PubMed: 1496141]
142.
Nygaard K , Hagen S , Hansen HS . et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The Second Scandinavian Trial in Esophageal Cancer. World J Surg. 1992;16:1104–10. [PubMed: 1455880]
143.
Ando N , Iizuka T , Kakegawa T . et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group study. J Thorac Cardiovasc Surg. 1997;114:205–9. [PubMed: 9270637]
144.
Arnott SJ , Duncan W , Gignoux M . et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patients data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys. 1998;41:579–83. [PubMed: 9635705]
145.
Fok M , Sham JST , Shoy D . et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery. 1993;113:138–47. [PubMed: 8430362]
146.
Zierens HU , Muller JM , Jacobi CA . et al. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg. 1995;19:444–9. [PubMed: 7639004]
147.
Teniere P , Hay J-M . French University Association for Surgical Research. et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet. 1991;173:123–30. [PubMed: 1925862]
148.
Sur RK , Singh DP , Sharma SC . et al. Radiation therapy of esophageal cancer: role of high dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1992;22:1043–6. [PubMed: 1555950]
149.
Tanisada K , Techima T , Ikeda H . et al. Prognostic factors for patients with esophageal cancer. Radiat Med. 1998;16:461–8. [PubMed: 9929147]
150.
Akagi Y , Hirokawa Y , Kagemoto M . et al. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer. Int J Radiat Oncol Biol Phys. 1999;43:525–30. [PubMed: 10078632]
151.
Smolle-Juettner FM , Smolle J , Pakisch B . et al. Palliation of esophageal cancer in ill, inoperable patients: value of iridium 192 high-dose-rate intracavitary brachytherapy with and without external beam irradiation. Dis Esoph. 1990;3:59–65.
152.
Iwasa M , Ohmori Y , Iwasa Y . et al. Effect of multidisciplinary treatment with high dose rate intraluminal brachytherapy on survival in patients with unresectable esophageal cancer. Digest Surg. 1998;15:227–35. [PubMed: 9845590]
153.
Sur RK , Donde B , Levin VC , Mannell A . Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;15:447–53. [PubMed: 9457834]
154.
Kelsen D , Atiq OT . Therapy of upper gastrointestinal tract cancers. Curr Probl Cancer. 1991;15:235–94. [PubMed: 1743044]
155.
Stahl M , Wilke H , Meyer H-J . et al. 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus. Eur J Cancer. 1993;30A:325–8. [PubMed: 8204353]
156.
Ilson DH , Sirott M , Saltz L . et al. A phase II trial of interferon-α-2a, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer. 1995;75:2197–202. [PubMed: 7712428]
157.
Warner E , Jensen JL , Cripps C . et al. Outpatient 5-fluorouracil, folinic acid and cisplatin in patients with advanced esophageal carcinoma. Acta Oncologica. 1999;38:255–9. [PubMed: 10227449]
158.
Ilson DH , Ajani J , Bhalla K . et al. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol. 1998;16:1826–34. [PubMed: 9586897]
159.
Pentheroudakis G , Lim KC , Dunlop DJ . et al. Non-infusional 5-Fluorouracil, doxorubicin and cisplatin in the treatment of locally advanced or metastatic gastro-oesophageal adenocarcinoma. Acta Oncologica. 2001;40:855–61. [PubMed: 11859986]
160.
Polee MB , Verweij J , Siersema PD . et al. Phase I study of a weekly schedule of a fixed dose of cisplatin and escalation doses of paclitaxel in patients with advanced oesophageal cancer. Eur J Cancer. 2002;38:1495–500. [PubMed: 12110496]
161.
Ajani JA , Baker J , Pisters PWT . et al. CPT-11 plus cisplatin in patients with advanced, untreated gastric or esophagogastric junction carcinoma: results of a phase II study. Cancer. 2002;94:641–6. [PubMed: 11857295]
162.
Maipang T , Vasinanukorn P , Petpichetchian C . et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol. 1994;56:191–7. [PubMed: 7518020]
163.
Ancona E , Ruol A , Chiarion-Sileni V . et al. Studio prospettico randomizzato di chemioterapia neoadjuvante versus sola chirurgia nel cancro operabile (T2–3, ogni N, M0) dell'esophago. Acta Chirurgia Italiana. 1995;51:308–17.
165.
Pouliquen X , Levard H , Hay J-M . et al. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. Ann Surg. 1996;223:127–33. [PMC free article: PMC1235087] [PubMed: 8597505]
166.
Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727–33. [PubMed: 12049861]
167.
Le Prise E , Etienne PL , Meunier B . et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer. 1994;73:1779–84. [PubMed: 8137201]
168.
Bedenne L , Bouche MO , Triboulet J-P . et al. Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102) [abstract] Proc Am Soc Clin Oncol. 2002;21:130a.
169.
Walsh TN , Noonan N , Hollywood D . et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–7. [PubMed: 8672151]
170.
Bosset J-F , Gignoux M , Triboulet J-P . et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337:161–7. [PubMed: 9219702]
171.
Urba S , Orringer M , Turrisi A . et al. Randomized preoperative locoregional chemoradiation versus surgery alone in patients with resectable esophageal cancer. J Clin Oncol. 2001;19:305–13. [PubMed: 11208820]
172.
Burmeister BH , Smithers BM , Fitzgerald L . et al. A randomized phase III trial of preoperative chemoradiation followed by surgery *CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus [abstract] Proc Am Soc Clin Oncol. 2002;21:130a.
173.
McCaughan JS Jr, Ellison EC , Guy JT . et al. Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. Ann Thorac Surg. 1996;62:1005–10. [PubMed: 8823080]
174.
Gossner L , Stolte M , Sroka R . et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 1998;114:448–55. [PubMed: 9496934]
175.
Savary JF , Grosjean P , Monnier P . et al. Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases. Endoscopy. 1998;30:258–65. [PubMed: 9615874]
176.
Overholt BF , Panjehpour M , Haydek JM . Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc. 1999;49:1–7. [PubMed: 9869715]
177.
Ferguson MK , Naunheim KS . Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 1997;114:824–9. [PubMed: 9375613]
178.
Reed CE . Comparison of different treatments for unresectable esophageal cancer. World J Surg. 1995;19:828–35. [PubMed: 8553674]
179.
Fleischman EH , Kagan AR , Bellotti JE . et al. Effective palliation for inoperable esophageal cancer using intensive intracavitary radiation. J Surg Oncol. 1990;44:234–7. [PubMed: 1696673]
180.
Harvey JC , Fleishman EH , Bellotti JE . et al. Intracavitary radiation in the treatment of advanced esophageal carcinoma: a comparison of high dose rate vs low dose rate brachytherapy. J Surg Oncol. 1993;52:101–4. [PubMed: 7682263]
181.
Lightdale CJ , Heier SK , Marcon NE . et al. Photodynamic therapy with profimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc. 1995;42:507–12. [PubMed: 8674919]
182.
Lam YH , Chan A , Lau J . et al. Self-expandable metal stents for malignant dysphagia. Aust NZ J Surg. 1999;69:668–71. [PubMed: 10515342]
183.
Sanyika C , Corr P , Haffejee A . Palliative treatment of oesophageal carcinoma-efficacy of plastic versus self-expandable stents. S Afr Med J. 1999;89:640–3. [PubMed: 10443214]
184.
Meunier B , Stasik C , Raoul J-L . et al. Gastric bypass for malignant esophagotracheal fistula. Eur J Cardio-Thorac Surg. 1998;13:184–9. [PubMed: 9583825]
185.
Raijman I , Lynch P . Coated expandable esophageal stents in the treatment of digestive-respiratory fistulas. Am J Gastroenterol. 1997;92:2188–91. [PubMed: 9399749]
186.
Low DE , Kozarek RA . Comparison of conventional and wire mesh expandable prostheses and surgical bypass in patients with malignant esophagorespiratory fistulas. Ann Thorac Surg. 1998;65:919–23. [PubMed: 9564901]

By agreement with the publisher, this book is accessible by the search feature, but cannot be browsed.

Copyright © 2003, BC Decker Inc.
Bookshelf ID: NBK13082

Views

  • Cite this Page

Related Items in Bookshelf

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...